【摘 要】
:
Although doxorubicin has become a key drug in cancer treatment,the resistance of colorectal carcinoma to doxorubicin is a major problem in clinical practice.F-b
【机 构】
:
Hubei Province Key Laboratory on Cardiovascular,Cerebrovascular and Metabolic Disorders,Hubei Univer